0,936  0,002  GST A substrate
0,866  0,004  Caspase 9 stimulant
0,850  0,004  Skin irritative effect
0,805  0,004  Platelet antagonist
0,805  0,005  Eye irritation, high
0,783  0,004  Vasodilator, peripheral
0,792  0,017  Antiinflammatory
0,771  0,005  Cholesterol antagonist
0,762  0,002  GST P1-1 substrate
0,760  0,010  TNF expression inhibitor
0,748  0,005  Lipoprotein disorders treatment
0,732  0,005  NOS3 expression inhibitor
0,712  0,002  GST M1-1 substrate
0,687  0,005  Antiglaucomic
0,683  0,011  Antihypercholesterolemic
0,678  0,008  Atherosclerosis treatment
0,664  0,005  Antimutagenic
0,664  0,010  Antithrombotic
0,659  0,005  Antipruritic, allergic
0,683  0,034  Apoptosis agonist
0,649  0,005  Platelet aggregation inhibitor
0,645  0,005  Hypolipemic
0,650  0,012  Radioprotector
0,637  0,005  Angiogenesis stimulant
0,638  0,006  Apoptosis antagonist
0,637  0,017  CYP2C9 substrate
0,613  0,005  Vasodilator
0,612  0,013  CYP2C19 substrate
0,605  0,010  Cardioprotectant
0,608  0,017  Carcinogenic
0,580  0,005  Antiulcerative
0,577  0,015  CTGF expression inhibitor
0,578  0,017  Antiallergic
0,585  0,025  Teratogen
0,586  0,033  Transcription factor NF kappa B inhibitor
0,573  0,024  Embryotoxic
0,551  0,004  Platelet adhesion inhibitor
0,550  0,007  Antihypertriglyceridemic
0,558  0,015  UGT1A9 substrate
0,550  0,011  FMO1 substrate
0,540  0,003  Protein kinase stimulant
0,542  0,008  Antidiabetic symptomatic
0,539  0,006  UGT2B4 substrate
0,537  0,005  Diabetic retinopathy treatment
0,533  0,003  Vanilloid agonist
0,536  0,014  Lipoxygenase inhibitor
0,533  0,011  Tumour necrosis factor alpha release inhibitor
0,538  0,017  Hepatic disorders treatment
0,521  0,005  Phospholipase C inhibitor
0,518  0,004  Abortion inducer
0,529  0,016  NOS2 expression inhibitor
0,534  0,024  Immunosuppressant
0,521  0,013  Antipyretic
0,507  0,005  VCAM1 expression inhibitor
0,521  0,019  Ulceration
0,518  0,018  Caspase 3 stimulant
0,510  0,012  UGT1A6 substrate
0,502  0,023  Immunomodulator
0,489  0,011  Myocardial infarction treatment
0,521  0,044  Antidiabetic
0,521  0,044  Cyclophilin D inhibitor
0,504  0,028  Respiratory analeptic
0,489  0,014  ICAM1 expression inhibitor
0,493  0,021  Antipsoriatic
0,479  0,009  Anesthetic general
0,473  0,004  Antipruritic, non-allergic
0,489  0,024  Antifungal
0,481  0,022  Mutagenic
0,485  0,028  CYP2C19 inhibitor
0,488  0,031  Stroke treatment
0,481  0,024  Analeptic
0,459  0,009  Non-steroidal antiinflammatory agent
0,474  0,024  Sensitization
0,454  0,009  Hair growth stimulant
0,456  0,015  Vascular (periferal) disease treatment
0,454  0,014  Antihypoxic
0,457  0,020  Hypoglycemic
0,470  0,035  GABA C receptor rho-3 antagonist
0,457  0,021  Antidiabetic (type 2)
0,459  0,026  Chemoprotective
0,466  0,034  Immunostimulant
0,475  0,046  15-Lipoxygenase inhibitor
0,440  0,011  Septic shock treatment
0,447  0,019  Antiparasitic
0,453  0,026  Antioxidant
0,450  0,023  Proliferative diseases treatment
0,430  0,005  Aldehyde dehydrogenase inhibitor
0,448  0,024  Cardiovascular analeptic
0,428  0,005  Interleukin 4 antagonist
0,438  0,016  Sedative
0,426  0,004  Phospholipase A2 inhibitor
0,449  0,031  Spasmolytic
0,462  0,044  Histamine release inhibitor
0,413  0,005  Insulin sensitizer
0,428  0,020  Radiosensitizer
0,409  0,004  Antihelmintic (Nematodes)
0,413  0,012  5 Hydroxytryptamine uptake stimulant
0,403  0,005  Gastrin inhibitor
0,399  0,004  Antieczematic
0,398  0,003  Toll-Like receptor 2 antagonist
0,427  0,040  5 Hydroxytryptamine release stimulant
0,403  0,018  RNA-directed DNA polymerase inhibitor
0,438  0,053  CYP3A4 substrate
0,392  0,012  UGT2B7 substrate
0,384  0,014  Antiseptic
0,376  0,007  CYP2B6 inhibitor
0,385  0,017  UGT1A4 substrate
0,373  0,006  UGT2B1 substrate
0,374  0,010  Muscular dystrophy treatment
0,369  0,004  TRPA1 agonist
0,382  0,018  Antihelmintic
0,372  0,010  Acaricide
0,423  0,065  5 Hydroxytryptamine release inhibitor
0,369  0,014  UGT1A3 substrate
0,360  0,007  Antihyperlipoproteinemic
0,394  0,042  Antihypertensive
0,393  0,042  AR expression inhibitor
0,378  0,027  Antineoplastic (liver cancer)
0,375  0,025  Transcription factor STAT3 inhibitor
0,353  0,004  Vanilloid 1 agonist
0,386  0,038  Cytotoxic
0,379  0,030  Chemopreventive
0,380  0,034  Interleukin 2 agonist
0,359  0,014  Carcinogenic, group 3
0,347  0,003  UGT2B10 substrate
0,357  0,018  Hepatoprotectant
0,343  0,007  5-Lipoxygenase inhibitor
0,343  0,008  DNA polymerase I inhibitor
0,350  0,015  Anesthetic
0,349  0,016  Tyrosine 3 hydroxylase inhibitor
0,359  0,027  Interleukin agonist
0,393  0,061  CYP2C9 inhibitor
0,345  0,014  Monophenol monooxygenase inhibitor
0,362  0,031  FMO3 substrate
0,334  0,005  Adenylate kinase inhibitor
0,342  0,014  Lipid peroxidase inhibitor
0,358  0,031  Transcription factor STAT inhibitor
0,403  0,076  Antibacterial
0,335  0,010  Glutathione S-transferase substrate
0,369  0,046  CYP1A2 substrate
0,328  0,007  Succinate dehydrogenase inhibitor
0,359  0,039  Antiprotozoal (Leishmania)
0,415  0,097  Antineoplastic (solid tumors)
0,323  0,006  Mediator release inhibitor
0,366  0,050  Antiischemic
0,319  0,004  Photosensitizer
0,344  0,033  Nitric oxide antagonist
0,317  0,009  Carcinogenic, group 1
0,313  0,005  Alcohol dehydrogenase substrate
0,348  0,041  Sodium/bile acid cotransporter inhibitor
0,310  0,004  Calcium antagonist
0,309  0,004  Transcription factor NF kappa B stimulant
0,359  0,054  CYP2D6 substrate
0,318  0,017  Interferon gamma antagonist
0,306  0,006  Uterine stimulant
0,333  0,034  DNA synthesis inhibitor
0,303  0,006  Catalase inhibitor
0,312  0,020  Melanin inhibitor
0,304  0,012  Alkylator
0,330  0,044  Free radical scavenger
0,299  0,015  Corneal wound healing stimulator
0,383  0,101  Antiarthritic
0,335  0,056  Antineoplastic (pancreatic cancer)
0,309  0,030  UGT1A1 substrate
0,296  0,019  Sepsis treatment
0,297  0,020  Skin whitener
0,327  0,051  Antineoplastic (multiple myeloma)
0,289  0,016  Interleukin 6 antagonist
0,273  0,003  Arachidonic acid antagonist
0,338  0,070  Bone diseases treatment
0,271  0,004  Thioredoxin inhibitor
0,270  0,004  Prolactin inhibitor
0,330  0,066  Vasodilator, coronary
0,277  0,012  Cystathionine beta-synthase inhibitor
0,279  0,016  Acute respiratory distress syndrome (ARDS) treatment
0,294  0,037  UDP-glucuronosyltransferase substrate
0,262  0,005  Aldehyde dehydrogenase substrate
0,302  0,047  Interleukin antagonist
0,262  0,009  Catenin beta inhibitor
0,300  0,050  Antineoplastic (lymphoma)
0,274  0,025  Protein-tyrosine phosphatase inhibitor
0,251  0,003  Endocannabinoid uptake inhibitor
0,289  0,045  Psychostimulant
0,278  0,035  DNA methyltransferase I inhibitor
0,270  0,026  Antiacne
0,245  0,004  Oleamide hydrolase inhibitor
0,248  0,007  Coagulant
0,253  0,015  Toll-Like receptor antagonist
0,245  0,007  Gastric antisecretory
0,247  0,014  GABA C receptor agonist
0,237  0,004  Toll-Like receptor 4 antagonist
0,308  0,075  12-Lipoxygenase inhibitor
0,247  0,014  ATPase inhibitor
0,242  0,010  Choleretic
0,259  0,027  Skeletal muscle relaxant
0,292  0,060  DNA damaging
0,311  0,081  Calcium channel activator
0,234  0,004  Prostaglandin F2 alpha antagonist
0,235  0,005  Glycine transporter 2 inhibitor
0,289  0,060  Flavin-containing monooxygenase substrate
0,233  0,004  Acetyl-CoA transferase inhibitor
0,240  0,013  Antibacterial (Helicobacter pylori)
0,238  0,012  Microtubule formation inhibitor
0,237  0,011  Antirickettsial
0,229  0,005  Adenylate cyclase stimulant
0,321  0,098  Toll-Like receptor agonist
0,247  0,025  Antipruritic
0,225  0,005  Prostaglandin EP2 antagonist
0,236  0,017  Cell adhesion inhibitor
0,286  0,067  Insulysin inhibitor
0,254  0,036  Neurotrophic factor enhancer
0,238  0,020  Antifungal enhancer
0,231  0,013  Retinoprotector
0,220  0,003  Prostaglandin agonist
0,247  0,031  Tumour necrosis factor antagonist
0,229  0,017  GABA C receptor rho-2 antagonist
0,216  0,004  Restless leg syndrome treatment
0,218  0,006  Toll-Like receptor 2 agonist
0,236  0,025  Alpha-N-acetylglucosaminidase inhibitor
0,213  0,003  Vanilloid 2 antagonist
0,214  0,005  Leukotriene antagonist
0,272  0,062  Superoxide dismutase inhibitor
0,215  0,007  Electron transport complex I inhibitor
0,210  0,004  Glycine receptor agonist
0,211  0,005  Interferon agonist
0,231  0,026  Genotoxic
0,245  0,043  P-glycoprotein inhibitor
0,224  0,022  Cholesterol synthesis inhibitor
0,204  0,003  Ca2+-transporting ATPase inhibitor
0,248  0,049  DNA methylase inhibitor
0,228  0,029  Bone formation stimulant
0,204  0,005  Amidase inhibitor
0,248  0,050  Wound healing agent
0,256  0,061  Cyclic AMP phosphodiesterase inhibitor
0,249  0,056  Antihypotensive
0,258  0,065  Cardiodepressant
0,207  0,015  Carbonic anhydrase III inhibitor
0,268  0,076  Aldehyde oxidase inhibitor
0,195  0,003  Lysophosphatidic acid 2 receptor antagonist
0,198  0,007  Peroxisome proliferator-activated receptor gamma agonist
0,195  0,005  UGT2B11 substrate
0,215  0,025  Protein-tyrosine phosphatase 1B inhibitor
0,193  0,006  Acyl-CoA dehydrogenase inhibitor
0,192  0,005  Ornithine decarboxylase inhibitor
0,200  0,014  Contraceptive female
0,200  0,013  Mucolytic
0,195  0,010  Actinic keratosis treatment
0,204  0,020  Expectorant
0,242  0,059  Antiparkinsonian, rigidity relieving
0,187  0,006  Leukotriene synthesis inhibitor
0,191  0,011  Sphingosine 1-phosphate receptor 4 antagonist
0,218  0,040  LDLR expression enhancer
0,192  0,014  GABA C receptor antagonist
0,211  0,034  UGT2B9 substrate
0,185  0,008  GST T1-1 substrate
0,187  0,010  GABA C receptor rho-1 antagonist
0,211  0,035  Neuropathy treatment
0,202  0,027  Neurotrophic factor
0,187  0,012  Sphingomyelinase inhibitor
0,183  0,008  CDC25A inhibitor
0,210  0,039  UGT2B15 substrate
0,202  0,032  Anesthetic local
0,218  0,048  Muscle relaxant
0,255  0,088  Antiosteoporotic
0,215  0,049  Histone acetyltransferase inhibitor
0,181  0,015  Antiviral (Influenza B)
0,223  0,056  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,196  0,031  Cell wall synthesis inhibitor
0,188  0,023  Cyclooxygenase 3 inhibitor
0,202  0,038  Antidote
0,237  0,073  Cytostatic
0,171  0,008  Acetylcholine release stimulant
0,176  0,012  Myasthenia Gravis treatment
0,181  0,018  Antineoplastic, alkylator
0,178  0,016  Arylamine N-Acetyltransferase substrate
0,171  0,009  Anabolic
0,168  0,007  Cannabinoid CB2 receptor antagonist
0,236  0,077  Antiamyloidogenic
0,183  0,027  Ferrochelatase inhibitor
0,181  0,025  Hearing loss treatment
0,190  0,034  Raynaud's phenomenon treatment
0,160  0,004  Antiviral (Parainfluenza)
0,170  0,015  Phosphofructokinase-1 inhibitor
0,198  0,043  Antiparkinsonian, tremor relieving
0,191  0,036  Hemostatic
0,171  0,017  Caspase 3 inhibitor
0,232  0,079  Antineoplastic (lymphocytic leukemia)
0,172  0,019  Sphingosine 1-phosphate receptor 2 antagonist
0,170  0,018  Antispirochetal
0,154  0,003  Lysophosphatidic acid 3 receptor antagonist
0,214  0,062  Pneumotoxic
0,177  0,026  Sphingosine 1-phosphate receptor 5 antagonist
0,154  0,005  Leukotriene B4 antagonist
0,154  0,004  Thromboxane antagonist
0,148  0,001  Lysophosphatidic acid receptor 3 agonist
0,168  0,024  Gastritis treatment
0,251  0,108  Antimycobacterial
0,147  0,005  Interferon inducer
0,170  0,029  Antiviral (Poxvirus)
0,219  0,079  Antiviral (West Nile virus)
0,198  0,058  Lipocortins synthesis antagonist
0,144  0,004  Thromboxane A2 antagonist
0,200  0,060  Antiviral (Ebola)
0,271  0,133  Antineoplastic (breast cancer)
0,235  0,098  Huntington's disease treatment
0,148  0,010  Lipase inhibitor
0,144  0,007  Peroxisome proliferator-activated receptor alpha agonist
0,170  0,034  Farnesoid X receptor antagonist
0,171  0,036  Antifungal (Cryptococcus)
0,191  0,056  Thrombolytic
0,147  0,012  Lanosterol 14 alpha demethylase inhibitor
0,142  0,007  Elastase 1 inhibitor
0,163  0,030  Menstruation disorders treatment
0,134  0,001  Lysophosphatidic acid receptor 1 agonist
0,153  0,021  Carbonic anhydrase XIII inhibitor
0,153  0,021  Folate antagonist
0,135  0,005  Estrogen-related receptor beta agonist
0,139  0,010  GABA aminotransferase inhibitor
0,161  0,032  Retinopathy treatment
0,183  0,054  Phobic disorders treatment
0,136  0,008  Granulocyte macrophage colony stimulating factor agonist
0,149  0,021  Antifungal (Pneumocystis)
0,131  0,004  Acetyl-CoA transferase 1 inhibitor
0,131  0,004  Thromboxane synthase inhibitor
0,238  0,112  Hypoxia-inducible factor 1 alpha inhibitor
0,139  0,013  Glutamate release inhibitor
0,179  0,054  Diuretic
0,173  0,048  Antidiabetic (type 1)
0,142  0,019  Selectin antagonist
0,160  0,037  Antiprotozoal (Amoeba)
0,133  0,012  Glycine receptor antagonist
0,170  0,049  Antiprotozoal (Coccidial)
0,136  0,015  Antifungal (Candida)
0,185  0,065  Growth hormone agonist
0,138  0,018  Glutamate dehydrogenase inhibitor
0,156  0,036  Antineoplastic antimetabolite
0,155  0,037  Beta amyloid protein antagonist
0,141  0,023  Cathepsin G inhibitor
0,130  0,013  Sphingosine 1-phosphate receptor 4 agonist
0,134  0,019  Interleukin 12 antagonist
0,149  0,036  SULT1A1 substrate
0,119  0,006  Aconitate hydratase inhibitor
0,172  0,059  Neurotensin receptor agonist
0,131  0,018  Cannabinoid receptor antagonist
0,284  0,171  Calcium channel L-type activator
0,155  0,043  Cathepsin H inhibitor
0,124  0,012  Antiviral (Hepatitis A)
0,142  0,030  Potassium channel (Ca-activated) activator
0,220  0,109  Amyotrophic lateral sclerosis treatment
0,116  0,005  Fumarate hydratase inhibitor
0,135  0,024  Carbonic anhydrase VI inhibitor
0,141  0,030  Antineoplastic alkaloid
0,128  0,017  Antiprotozoal activity enhancer
0,230  0,120  Prostate cancer treatment
0,123  0,014  Cannabinoid CB1 receptor agonist
0,113  0,004  Anesthetic inhalation
0,128  0,019  Interleukin 5 antagonist
0,124  0,017  ATPase (Vacuolar H+) inhibitor
0,229  0,123  Metabolic disease treatment
0,151  0,044  Heat shock protein 70 antagonist
0,126  0,020  Glutathione S-transferase inhibitor
0,125  0,020  Antileprosy
0,133  0,028  Electrolyte absorption antagonist
0,125  0,020  Keratolytic
0,116  0,012  CDC25B inhibitor
0,159  0,055  Pancreatic disorders treatment
0,169  0,066  Antiviral (Hepatitis C)
0,116  0,014  Prostaglandin antagonist
0,114  0,013  Antidote, heavy metal
0,105  0,004  Prostaglandin E2 agonist
0,110  0,009  Antimycoplasmal
0,115  0,015  Narcotic antagonist
0,215  0,115  Antituberculosic
0,122  0,023  Cell adhesion molecule inhibitor
0,237  0,138  Antileukemic
0,147  0,048  Proteasome inhibitor
0,111  0,013  Anticholelithogenic
0,099  0,002  Prostaglandin F2 alpha agonist
0,155  0,058  Antianemic
0,101  0,004  Leukotriene C antagonist
0,108  0,011  Vanilloid 4 agonist
0,120  0,023  Tocolytic
0,176  0,080  Antiviral (Hepatitis)
0,124  0,028  Paget's disease treatment
0,203  0,108  Antineoplastic (renal cancer)
0,113  0,019  Potassium channel large-conductance Ca-activated activator
0,159  0,065  Antiischemic, cerebral
0,174  0,079  Diabetic nephropathy treatment
0,114  0,020  Na+ K+ transporting ATPase inhibitor
0,130  0,037  Neutropenia treatment
0,247  0,155  Antineoplastic (endocrine cancer)
0,097  0,006  Acetyl-CoA transferase 2 inhibitor
0,096  0,005  Glucose-6-phosphate isomerase inhibitor
0,105  0,015  Cannabinoid CB1 receptor antagonist
0,128  0,037  DOPA decarboxylase inhibitor
0,093  0,003  Prostaglandin D2 agonist
0,099  0,009  Nitric oxide donor
0,100  0,011  Gaucher disease treatment
0,112  0,024  Glutamate decarboxylase inhibitor
0,093  0,004  Membrane dipeptidase inhibitor
0,102  0,014  Peroxisome proliferator-activated receptor gamma antagonist
0,101  0,014  Phospholipase D inhibitor
0,124  0,037  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,098  0,011  Glutamate (mGluR6) antagonist
0,144  0,058  Cocaine dependence treatment
0,102  0,017  Antiemphysemic
0,096  0,012  Fatty acid synthase inhibitor
0,164  0,080  Macular degeneration treatment
0,117  0,034  Triose-phosphate isomerase inhibitor
0,100  0,016  Antimetabolite
0,211  0,127  Antiepileptic
0,225  0,142  Antineoplastic (lung cancer)
0,158  0,075  Cystic fibrosis treatment
0,101  0,018  Alcohol oxidase inhibitor
0,148  0,065  Amylase inhibitor
0,083  0,002  Carbonic anhydrase X inhibitor
0,083  0,002  Carbonic anhydrase VIII inhibitor
0,104  0,023  Epoxide hydrolase inhibitor
0,116  0,036  Tourette's syndrome treatment
0,084  0,004  Prostaglandin EP4 agonist
0,084  0,005  Pregnane X receptor antagonist
0,173  0,093  Amyloid beta aggregation inhibitor
0,223  0,144  CYP3A4 inhibitor
0,101  0,022  Hyperparathyroidism treatment
0,099  0,021  Carbamoyl phosphate synthetase inhibitor
0,143  0,067  CNS active muscle relaxant
0,187  0,110  Antineoplastic (cervical cancer)
0,123  0,047  AMP-activated protein kinase stimulant
0,080  0,004  Prostacyclin agonist
0,199  0,123  Antineoplastic (ovarian cancer)
0,109  0,033  Bile acid receptor antagonist
0,176  0,101  VEGF expression inhibitor
0,110  0,035  Antidote, mercury
0,236  0,161  Toll-Like receptor 7 agonist
0,083  0,008  Squalene synthetase inhibitor
0,094  0,019  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,082  0,007  Retinoid X receptor agonist
0,077  0,004  Prostaglandin EP2 agonist
0,150  0,078  Peroxidase inhibitor
0,135  0,063  Antihelmintic (Trematoda)
0,088  0,016  Exportin-1 inhibitor
0,079  0,007  Cholesterol esterase inhibitor
0,076  0,004  Kainate receptor agonist
0,130  0,059  Antiviral (Papilloma)
0,109  0,038  Antiviral (Rhinovirus)
0,090  0,020  Protease 3C (Human rhinovirus) inhibitor
0,101  0,031  mTOR complex 2 inhibitor
0,147  0,078  Movement disorders treatment
0,073  0,004  Leukotriene C4 antagonist
0,076  0,007  Leukotriene D4 antagonist
0,078  0,010  Adenosine deaminase inhibitor
0,142  0,074  SULT1A3 substrate
0,088  0,020  Uterine relaxant
0,080  0,013  Lipocortins synthesis agonist
0,077  0,010  Ryanodine receptor antagonist
0,166  0,099  Antiarrhythmic
0,079  0,013  Leukocyte elastase inhibitor
0,077  0,011  Squalene epoxidase inhibitor
0,082  0,016  Carbonic anhydrase XIV inhibitor
0,107  0,041  Carcinogenic, group 2A
0,082  0,017  Potassium channel intermediate-conductance Ca-activated blocker
0,086  0,022  Potassium channel (Tandem pore domain) blocker
0,069  0,005  1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor
0,119  0,055  Excitatory amino acid transporter EAAC1 inhibitor
0,120  0,057  GABA receptor agonist
0,101  0,039  Topoisomerase II alpha inhibitor
0,140  0,079  Thiol protease inhibitor
0,064  0,003  Elastase 3A inhibitor
0,064  0,003  Elastase 2B inhibitor
0,064  0,003  Elastase 3B inhibitor
0,187  0,126  Calpain inhibitor
0,115  0,055  Aminopeptidase B inhibitor
0,123  0,063  Autism spectrum disorders treatment
0,144  0,085  Pulmonary hypertension treatment
0,104  0,045  Antineoplastic antibiotic
0,062  0,003  Calcium-independent phospholipase A2 inhibitor
0,211  0,152  Thyroid hormone antagonist
0,065  0,006  Prostaglandin EP4 antagonist
0,093  0,035  Histidine decarboxylase inhibitor
0,073  0,015  Antiviral (Herpesvirus 3, Human)
0,144  0,086  Hexokinase inhibitor
0,142  0,085  Urolithiasis treatment
0,109  0,054  Bronchodilator
0,058  0,004  Lysophosphatidic acid 1 receptor antagonist
0,064  0,010  Retinoid X alpha receptor agonist
0,112  0,060  Falcipain 3 inhibitor
0,203  0,151  Thyroid hormone beta antagonist
0,063  0,011  Benzodiazepine antagonist
0,086  0,034  Calcium channel L-type blocker
0,078  0,026  Argininosuccinate synthase inhibitor
0,076  0,024  Carbonic anhydrase VB inhibitor
0,069  0,018  Nicotinic alpha3beta2 receptor antagonist
0,062  0,011  Cytokine production stimulant
0,061  0,013  Geranyltranstransferase inhibitor
0,072  0,025  Ornithine carbamoyltransferase inhibitor
0,088  0,040  Antibiotic
0,154  0,107  Antineoplastic (bone cancer)
0,182  0,136  Antiprotozoal (Trypanosoma)
0,047  0,002  Thromboxane A2 agonist
0,123  0,078  Cyclooxygenase 1 inhibitor
0,069  0,025  Sphingosine kinase inhibitor
0,063  0,019  CD45 antagonist
0,072  0,028  Maillard reaction inhibitor
0,114  0,070  Interleukin 8 antagonist
0,049  0,006  Epoxide hydrolase 1 inhibitor
0,073  0,030  TRPA1 antagonist
0,075  0,034  Glutamate (mGluR7) antagonist
0,085  0,044  Porphobilinogen synthase inhibitor
0,052  0,011  Retinoid X receptor antagonist
0,083  0,042  Antidote, organophosphates
0,043  0,002  Thromboxane agonist
0,049  0,009  Vanilloid 3 antagonist
0,073  0,033  NMDA receptor agonist
0,077  0,037  Cannabinoid receptor agonist
0,048  0,008  Leukotriene B4 receptor 1 antagonist
0,123  0,084  Interleukin 1 antagonist
0,217  0,177  Inflammatory Bowel disease treatment
0,069  0,029  Ribonucleoside-diphosphate reductase inhibitor
0,048  0,008  HMG CoA reductase inhibitor
0,085  0,046  Sleep apnea treatment
0,186  0,147  CYP1A2 inhibitor
0,064  0,026  Autotaxin inhibitor
0,070  0,031  Ribonucleotide reductase inhibitor
0,143  0,105  Myocardial ischemia treatment
0,099  0,061  Creatine kinase inhibitor
0,099  0,062  Anticataract
0,043  0,006  Elastase 2A inhibitor
0,043  0,006  Elastase 2 inhibitor
0,041  0,004  Calcium-dependent phospholipase A2 inhibitor
0,067  0,029  Sphingosine 1-phosphate receptor 3 antagonist
0,103  0,066  Antiinfertility, female
0,151  0,114  Antiviral (Influenza)
0,157  0,120  Anticonvulsant
0,076  0,040  Carbonic anhydrase VA inhibitor
0,050  0,013  Prostacyclin antagonist
0,098  0,062  Xanthine oxidase inhibitor
0,047  0,011  Prostaglandin EP3 antagonist
0,085  0,049  Thioredoxin reductase inhibitor
0,049  0,013  Peroxisome proliferator-activated receptor delta agonist
0,127  0,091  Cyclooxygenase inhibitor
0,051  0,015  Factor XIIIa inhibitor
0,112  0,079  Growth stimulant
0,060  0,027  Alpha-mannosidase inhibitor
0,057  0,024  HCV NS3/NS4A protease inhibitor
0,061  0,030  Sphingosine kinase 2 inhibitor
0,110  0,079  Transcription factor STAT6 inhibitor
0,043  0,012  Retinoid X alpha receptor antagonist
0,037  0,006  Toll-Like receptor 4 agonist
0,037  0,007  Prostaglandin H2 antagonist
0,118  0,090  Calcium channel blocker
0,059  0,031  Sphingosine 1-phosphate receptor 1 antagonist
0,040  0,012  Methionyl aminopeptidase 1 inhibitor
0,184  0,155  Antineoplastic (sarcoma)
0,053  0,024  Microtubule stabilization
0,094  0,066  Interleukin 1 beta converting enzyme inhibitor
0,032  0,004  Isoleucine-tRNA ligase inhibitor
0,044  0,016  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,088  0,060  NADH dehydrogenase inhibitor
0,030  0,003  Carbonic anhydrase XI inhibitor
0,173  0,147  Antineoplastic (melanoma)
0,069  0,043  Carbonic anhydrase V inhibitor
0,043  0,018  Glutamate (mGluR8) agonist
0,129  0,103  Pregnane X receptor agonist
0,119  0,094  Antianorexic
0,078  0,053  Nicotinic alpha4beta2 receptor antagonist
0,032  0,008  Vanilloid 2 agonist
0,043  0,019  Inosine monophosphate dehydrogenase inhibitor
0,098  0,073  HDL-cholesterol increasing
0,154  0,132  Growth factor agonist
0,054  0,031  Prolyl endopeptidase inhibitor
0,094  0,071  Sulfotransferase substrate
0,033  0,011  Peroxisome proliferator-activated receptor alpha antagonist
0,135  0,113  Dual specificity phosphatase inhibitor
0,107  0,086  Shock treatment
0,037  0,016  GABA transporter 3 inhibitor
0,031  0,010  Glucosylceramidase stimulant
0,041  0,020  Nicotinic acid receptor agonist
0,037  0,016  ATP citrate lysase inhibitor
0,042  0,022  Histone deacetylase 7 inhibitor
0,025  0,004  Vitamin D receptor agonist
0,159  0,139  Antineoplastic enhancer
0,059  0,040  VEGFR2 expression inhibitor
0,031  0,012  Hedgehog signaling activator
0,047  0,028  Mannosidase inhibitor
0,025  0,006  Toll-Like receptor 8 agonist
0,036  0,018  Melatonin receptor 1A agonist
0,021  0,003  Calcineurin inhibitor
0,024  0,008  Retinoid X beta receptor antagonist
0,024  0,009  Neuraminidase (Influenza B) inhibitor
0,030  0,015  Kynurenine 3 monooxygenase inhibitor
0,067  0,052  SULT2A1 substrate
0,026  0,011  Leukotriene B4 receptor 2 antagonist
0,022  0,008  G-protein-coupled receptor 120 agonist
0,042  0,029  Angiotensin AT1 receptor antagonist
0,044  0,031  Sphingosine 1-phosphate receptor agonist
0,074  0,061  Sphingosine 1-phosphate receptor antagonist
0,078  0,065  Caspase 7 inhibitor
0,169  0,156  Nitric-oxide synthase stimulant
0,090  0,077  Phosphodiesterase 6D inhibitor
0,038  0,026  Farnesoid X receptor agonist
0,054  0,042  Beta 1 adrenoreceptor antagonist
0,031  0,020  Peptide deformylase inhibitor
0,034  0,023  Benzodiazepine receptor peripheral-type antagonist
0,053  0,042  Glucosylceramidase inhibitor
0,058  0,047  NMDA receptor glycine site agonist
0,159  0,148  Acute neurologic disorders treatment
0,045  0,035  Potassium channel Kv1.3 blocker
0,121  0,111  Restenosis treatment
0,036  0,026  Arginase inhibitor
0,052  0,042  Sphingosine 1-phosphate receptor 5 agonist
0,041  0,032  Guanylate cyclase inhibitor
0,065  0,056  MDM2 inhibitor
0,092  0,083  Antiprotozoal (Toxoplasma)
0,042  0,034  Purinergic P2Y antagonist
0,013  0,006  Immunosuppressant Cyclosporine-like
0,101  0,093  Antiviral (CMV)
0,071  0,064  GABA B receptor agonist
0,033  0,026  Phosphoglycerate kinase inhibitor
0,028  0,021  1,3-Beta-glucan synthase inhibitor
0,030  0,023  Cholesterol ester transfer protein antagonist
0,207  0,200  Antiobesity
0,023  0,016  Purinergic P2Y12 antagonist
0,049  0,043  Cannabinoid CB2 receptor agonist
0,078  0,072  T cell inhibitor
0,039  0,034  Sphingosine kinase 1 inhibitor
0,034  0,029  5-Alpha-reductase inhibitor
0,026  0,020  Nicotinic acid receptor 2 antagonist
0,048  0,044  Glucose-6-phosphate translocase inhibitor
0,110  0,106  Antihemorrhagic
0,050  0,046  Heparanase inhibitor
0,074  0,070  ErbB-3 antagonist
0,031  0,027  Glutamate (mGluR3) agonist
0,048  0,045  Elastase inhibitor
0,064  0,062  Aminopeptidase I inhibitor
0,032  0,029  Angiotensin II receptor antagonist
0,052  0,050  Biliverdin reductase inhibitor
0,052  0,050  Postcoital contraceptive
0,035  0,034  Kainate receptor antagonist
0,084  0,082  UDP-glucose 4-epimerase inhibitor

